Global Short-Read Sequencing Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
“Global Short-Read Sequencing Market” is an upcoming report by MarketResearch.biz. The global short-read sequencing market segmentation allows for deeper understanding and thought, to decisively assess, analyze, and study. Besides revenues for segments, global, regional, and country-wise, market revenue segmentation will be compiled in a scrupulous manner for clear flow and understanding. The analysis will be conducted using expert opinions and inputs, as well as comprehensive primary and secondary research efforts to establish various aspects of the short-read sequencing market. The global short-read sequencing market report will be segmented on the basis of product, technology, application, workflow, end-use, and region.
In DNA sequencing, a read is an inferred sequence of base pairs (or probabilities) corresponding to all or part of a single DNA fragment. The set of fragments is referred to as a sequencing library, which is sequenced to produce a set of reads. Short-read sequencing technology is easy to use and usually are generated in a single run.
The global short-read sequencing market is projected to expand at a high CAGR over the foreseeable future. Escalating demand for companion diagnostics and personalized medicine are projected to fuel market growth over the coming years. The initiation of targeted cancer therapeutics has greatly enhanced the acceptance of sequencing technologies in companion diagnostics.
As reported by the National Genome Human Research Institute (NHGRI) the cost of genome sequencing has declined significantly and this is projected to boost market growth. Various undertakings initiated by prominent market players to acquire a greater market share is expected to surge market growth in the coming years.
In terms of technology, the market is categorized into – next-generation sequencing and Sanger sequencing. The next-generation sequencing segment accounted for a majority revenue share in 2018 due to its cost-effective and rapid method for detection of genetic abnormalities. The Sanger sequencing method is practical for the consecutive analysis of a single nucleotide fragment. It is a quick and cost-effective method of sequencing when the number of targets is relatively low.
With respect to product, the market is segmented into – instruments, consumables and services. The consumables segment needs to be procured by end-users at regular intervals, and as such, accounted for a substantial revenue share of the market in 2018. But, the services segment is expected to index the quickest CAGR over the foreseeable future.
Regarding application in the market, the oncology segment accounted for a majority revenue share in 2018 and is projected to do so over the years to come.
The workflow of the market is categorized into – pre-sequencing, sequencing, and data analysis. Sequencing is the most crucial phase of the complete workflow, and as such, accounted for the largest revenue share of the market in 2018.
Academic research accounted for the largest revenue share of the end-use aspect of the market. An increase in the number of projects across academic institutes and universities is projected to fuel growth over the coming years. Contrastingly, the requirement for advanced technologies meant for clinical diagnostics is expected to play a crucial role in the growth of the clinical research segment.
The market in North America were frontrunners in the short-read sequencing market with a majority revenue share in 2018. This can be attributed to the availability of regulatory environments that support the development of genomics. The Asia Pacific market is projected to index the quickest growth in the years to come due to the evolving reimbursement framework in emerging economies.
Global Short-Read Sequencing Market Segmentation:
Global Short-Read Sequencing Market Segmentation, by Technology:
- Next-Generation Sequencing
- Sanger Sequencing
Global Short-Read Sequencing Market Segmentation, by Product:
Global Short-Read Sequencing Market Segmentation, by Application:
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
Global Short-Read Sequencing Market Segmentation, by Workflow:
- Data Analysis
Global Short-Read Sequencing Market Segmentation, by End-use:
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
Global Short-Read Sequencing Market Segmentation, by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche AG
- Qiagen N.V.
- Illumina Inc.
- Genscript Biotech Corporation
- 10x Genomics
- Macrogen Inc.
- Agilent Technologies
- BGI Genomics
- Fasteris SA
- GE healthcare
Request for TOC
Don't just take our word. We are trusted by these great companies!